Post-translational modification by ubiquitin and ubiquitin-like proteins (ublps) is a predominant cellular regulatory mechanism. Ubiquitination regulates a vast array of biological processes, including cell division, the immune response, and embryonic development. As a result, defects in the ubiquitin pathway are associated with numerous diseases, particularly cancer, and disorders associated with aging, such as neurodegenerative disorders and arid muscle wasting. In addition to ubiquitin, over 10 ublps have been found in higher eukaryotes. Ublps have structures and sequences that closely resemble ubiquitin, but they direct their targets to distinct destinies. Therefore, it is important to understand the molecular bases that define the specificity of the ubiquitination process. Our long-term goal is to understand how ubiquitin and ublps are directed to their particular targets to control processes involved in diseases such as cancers and neurodegenerative disorders. Ubiquitin is ligated to targets by a cascade involving a series of three enzymes in classes known as E1, E2, and E3. Despite the importance of these enzymes, little is known how ubiquitin is selected by ubiquitinating enzymes. We hypothesize that the specificity of ubiquitinating enzymes is dictated by a combination of positive selection for interacting with ubiquitin, and negative selection against the wrong ublp. We are focusing on the E1, E2 and E3 enzymes involved in cell proliferation and involved in regulating tumor suppressor proteins. Because these enzymes are important for cell proliferation, and play roles in pathways that lead to cancers, these enzymes may serve as good targets for anti-mitogenic agents. The recent approval of the proteasome inhibitor Bortezomib (VelcadeTM) for treatment of multiple myeloma underscores the therapeutic potential for targeting enzymes in the ubiquitin, and ublp, pathways, and highlights the importance of understanding the detailed mechanisms and specificities of these enzymes. We plan a multidisciplinary approach that combines biochemical, enzymological and structural analysis of ubiquitinating enzymes, enzymes in ublp conjugation cascades, mutants and complexes, in order to understand the specificity of ubiquitination. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM077053-01A1
Application #
7147800
Study Section
Macromolecular Structure and Function B Study Section (MSFB)
Program Officer
Jones, Warren
Project Start
2006-08-01
Project End
2010-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
1
Fiscal Year
2006
Total Cost
$121,688
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Zheng, Y; Qiu, Y; Gunderson, J E C et al. (2017) Production of Human ATG Proteins for Lipidation Assays. Methods Enzymol 587:97-113
Qiu, Y; Zheng, Y; Taherbhoy, A M et al. (2017) Crystallographic Characterization of ATG Proteins and Their Interacting Partners. Methods Enzymol 587:227-246
Kim, Myungjin; Sandford, Erin; Gatica, Damian et al. (2016) Mutation in ATG5 reduces autophagy and leads to ataxia with developmental delay. Elife 5:
Ordureau, Alban; Heo, Jin-Mi; Duda, David M et al. (2015) Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc Natl Acad Sci U S A 112:6637-42
Ordureau, Alban; Sarraf, Shireen A; Duda, David M et al. (2014) Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell 56:360-75
Klionsky, Daniel J; Schulman, Brenda A (2014) Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nat Struct Mol Biol 21:336-45
Hurley, James H; Schulman, Brenda A (2014) Atomistic autophagy: the structures of cellular self-digestion. Cell 157:300-311
Kaiser, Stephen E; Qiu, Yu; Coats, Julie E et al. (2013) Structures of Atg7-Atg3 and Atg7-Atg10 reveal noncanonical mechanisms of E2 recruitment by the autophagy E1. Autophagy 9:778-80
Qiu, Yu; Hofmann, Kay; Coats, Julie E et al. (2013) Binding to E1 and E3 is mutually exclusive for the human autophagy E2 Atg3. Protein Sci 22:1691-7
Lima, Christopher D; Schulman, Brenda A (2012) Structural biology: A protein engagement RING. Nature 489:43-4

Showing the most recent 10 out of 27 publications